Company Name, Ticker, Competitors, else..

Nymox Pharmaceutical Corporation (NYMX)

Sector • Healthcare Industry • In Vitro & In Vivo Diagnostic Substances

Industry • In Vitro & In Vivo Diagnostic Substances

Sector • Healthcare

Nymox Pharmaceutical's

Name: Nymox Pharmaceutical Corporation Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NYMX Sales vs. its Competitors Q4 2024

Comparing the current results to its competitors, Nymox Pharmaceutical reported Revenue decrease in the 4 quarter 2024 year on year by 0 %, slower than the combined decrease of the NYMX's competitors by -45.78 %, recorded in the same quarter.

• List of NYMX Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Nymox Pharmaceutical Corporation, faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< NYMX Stock Performance Comparisons

Nymox Pharmaceutical's Comment on Competition and Industry Peers

The company competes with major pharmaceutical, diagnostic, chemical, and biotechnology firms that have greater financial, technical, and marketing resources. Competitors also include biotechnology companies operating independently or in collaboration with large pharmaceutical firms in the research, development, and commercialization of potentially competitive products. Additionally, academic institutions, government agencies, and other public and private research organizations involved in Alzheimer's disease research and product commercialization contribute to the competitive environment.

<< See the full list of NYMX competitors

*Market share is calculated based on total revenue.

NYMX's Stock Performance relative to its Competitors

Publicly Traded Peers of Nymox Pharmaceutical Corporation

Athersys Inc
Share Performance

-96.93%

This Quarter

Athersys Inc

Profile

Athersys Inc's business model revolves around the development and commercialization of novel cellular therapeutics.

More about Athersys Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.000 mill.	$ - mill.	$ -83.371 mill.

Atossa Therapeutics Inc
Share Performance

-82.41%

One Year

Atossa Therapeutics Inc

Profile

Atossa Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for breast conditions and oncology.

More about Atossa Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 19.510 mill.	$ - mill.	$ -37.709 mill.

Ocugen Inc
Share Performance

-21.32%

This Quarter

Ocugen Inc

Profile

Ocugen Inc's business model is focused on the development and commercialization of innovative gene therapies to treat rare and underserved ocular diseases, with a particular emphasis on underserved patient populations. They aim to leverage their expertise in gene therapy and partnerships to advance novel treatments and bring them to market, ultimately improving the lives of patients in need.

More about Ocugen Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 343.760 mill.	$ 4.580 mill.	$ -81.811 mill.

Sources: Nymox Pharmaceutical Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 9:20 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nymox Pharmaceutical Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.